606O Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors
Authors:
- F. Meric-BernstamFMF. Meric-Bernstam
- Y. NaitoYNY. Naito
- S. GaillardSGS. Gaillard
- T. ShimoiTST. Shimoi
- V. ChungVCV. Chung
- A.A. DavisADA.A. Davis
- T. ProiaTPT. Proia
- A. AyyoubAAA. Ayyoub
- M. KulkarniMKM. Kulkarni
- S. UpadhyaySUS. Upadhyay
- N. MillerNMN. Miller
- N. LuheshiNLN. Luheshi
- 17 September 2024
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 35, S485-S486